SYNERGISTIC ACTIVATION OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PROMOTER BY THE VIRAL TAT PROTEIN AND CELLULAR TRANSCRIPTION FACTOR-SP1

被引:68
|
作者
KAMINE, J
CHINNADURAI, G
机构
关键词
D O I
10.1128/JVI.66.6.3932-3936.1992
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
We have previously shown that the human immunodeficiency virus type 1 (HIV-1) Tat protein can activate a synthetic promoter containing consensus-binding sites for the cellular transcription factor Sp1. In this report, we show that a GAL-Tat fusion protein targeted via GAL4 DNA-binding sites can also trans activate an HIV-1 LTR promoter independently of the trans-activation response region. To show that the trans activation of the promoter by Tat directly involves the Sp1 protein, we have targeted a GAL-Sp1 fusion protein to the long terminal repeat promoter via upstream GAL4-binding sites. In the presence of Tat and GAL-Sp1, the promoter is synergistically trans activated at the transcriptional level, indicating that Tat and Sp1 functionally interact to trans activate the HIV-1 promoter. The Sp1 synergism is relatively specific, since another chimeric transcriptional activator, GAL-VP16, does not appear to be significantly synergistic with Tat.
引用
收藏
页码:3932 / 3936
页数:5
相关论文
共 50 条
  • [41] Activation of Bcl-2 promoter-directed gene expression by the human immunodeficiency virus type-1 Tat protein
    Wang, ZD
    Morris, GF
    Reed, JC
    Kelly, GD
    Morris, CB
    VIROLOGY, 1999, 257 (02) : 502 - 510
  • [42] ACTIVATION OF THE HUMAN-IMMUNODEFICIENCY-VIRUS BY HERPES-SIMPLEX VIRUS TYPE-1
    OSTROVE, JM
    LEONARD, J
    WECK, KE
    RABSON, AB
    GENDELMAN, HE
    JOURNAL OF VIROLOGY, 1987, 61 (12) : 3726 - 3732
  • [43] THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REV PROTEIN - A PIVOTAL PROTEIN IN THE VIRAL LIFE-CYCLE
    HOPE, T
    POMERANTZ, RJ
    TRANSACTING FUNCTIONS OF HUMAN RETROVIRUSES, 1995, 193 : 91 - 105
  • [44] CYSTEINE RESIDUES IN THE VIF PROTEIN OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ARE ESSENTIAL FOR VIRAL INFECTIVITY
    MA, XY
    SOVA, P
    CHAO, W
    VOLSKY, DJ
    JOURNAL OF VIROLOGY, 1994, 68 (03) : 1714 - 1720
  • [45] HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION REQUIRES REVERSE TRANSCRIPTION OF NASCENT VIRAL-RNA
    POTASH, MJ
    LI, GR
    SHAHABUDDIN, M
    PELLEGRINO, MG
    VOLSKY, DJ
    DNA AND CELL BIOLOGY, 1993, 12 (08) : 685 - 693
  • [46] EFFECTS OF THE TAT BASIC DOMAIN ON HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 TRANSACTIVATION, USING CHEMICALLY SYNTHESIZED TAT PROTEIN AND TAT PEPTIDES
    VIVES, E
    CHARNEAU, P
    VANRIETSCHOTEN, J
    ROCHAT, H
    BAHRAOUI, E
    JOURNAL OF VIROLOGY, 1994, 68 (05) : 3343 - 3353
  • [47] EVIDENCE THAT A SEQUENCE SIMILAR TO TAR IS IMPORTANT FOR INDUCTION OF THE JC VIRUS LATE PROMOTER BY HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 TAT
    CHOWDHURY, M
    TAYLOR, JP
    CHANG, CF
    RAPPAPORT, J
    KHALILI, K
    JOURNAL OF VIROLOGY, 1992, 66 (12) : 7355 - 7361
  • [48] MODULATION OF INTERFERON-MEDIATED INHIBITION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 BY TAT
    SHIRAZI, Y
    POPIK, W
    PITHA, PM
    JOURNAL OF INTERFERON RESEARCH, 1994, 14 (05): : 259 - 263
  • [49] A SYNTHETIC RETINOID ANTAGONIST INHIBITS THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PROMOTER
    LEE, MO
    HOBBS, PD
    ZHANG, XK
    DAWSON, MI
    PFAHL, M
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (12) : 5632 - 5636
  • [50] ANALYSIS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PROMOTER INSERTION IN-VIVO
    RAINERI, I
    SOLER, M
    SENN, HP
    VIROLOGY, 1995, 208 (01) : 359 - 364